SCHEMBL14730255

SCHEMBL14730255

CCN(C(=O)c1cnc(N2C[C@H](NC(=O)OC(C)(C)C)[C@@H](c3cc(C)ccc3F)C2)nc1)C1CCN(c2nc([C@@H]3CCCO3)no2)CC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14730276 0.93
SCHEMBL14730219 0.92 PDK2 (0.36) PDK2
SCHEMBL14730259 0.88 PDK2 (0.36) PDK2
SCHEMBL14730217 0.88 GPR119 (0.34) PDK2
SCHEMBL14730173 0.88 PDK2 (0.34) PDK2
SCHEMBL14730207 0.88 NTRK1 (0.34)
SCHEMBL14730174 0.86 PDK2 (0.33) PDK2
SCHEMBL14730263 0.84 GPR119 (0.35) PDK2
SCHEMBL14730332 0.83
SCHEMBL14730318 0.83 NTRK1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed